[EN] CRYSTALLINE HYDRATE OF A JAK INHIBITOR COMPOUND<br/>[FR] HYDRATE CRISTALLIN D'UN COMPOSÉ INHIBITEUR DE JAK
申请人:THERAVANCE BIOPHARMA R&D IP LLC
公开号:WO2021178991A1
公开(公告)日:2021-09-10
Provided herein is a crystalline hydrate of the compound of formula 1:. Also provides herein are pharmaceutical compositions comprising such crystalline hydrate, methods of using such crystalline hydrate to treat respiratory diseases, and processes useful for preparing such crystalline hydrate.